First National Trust’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $19.1M | Sell |
87,859
-28,779
| -25% | -$6.38M | 0.65% | 41 |
|
|
2025
Q4 | $26.7M | Sell |
116,638
-7,068
| -6% | -$1.61M | 0.89% | 25 |
|
|
2025
Q3 | $28.6M | Sell |
123,706
-1,883
| -1% | -$383K | 0.98% | 22 |
|
|
2025
Q2 | $23.3M | Sell |
125,589
-2,254
| -2% | -$419K | 0.87% | 23 |
|
|
2025
Q1 | $26.8M | Sell |
127,843
-13,852
| -10% | -$2.69M | 1.08% | 19 |
|
|
2024
Q4 | $25.2M | Buy |
141,695
+11,045
| +8% | +$2.03M | 0.95% | 22 |
|
|
2024
Q3 | $25.8M | Sell |
130,650
-2,186
| -2% | -$408K | 1% | 20 |
|
|
2024
Q2 | $22.8M | Sell |
132,836
-4,538
| -3% | -$752K | 0.94% | 22 |
|
|
2024
Q1 | $25M | Sell |
137,374
-3,705
| -3% | -$639K | 1.02% | 19 |
|
|
2023
Q4 | $21.9M | Sell |
141,079
-8,970
| -6% | -$1.31M | 0.96% | 22 |
|
|
2023
Q3 | $22.4M | Sell |
150,049
-3,092
| -2% | -$454K | 1.07% | 21 |
|
|
2023
Q2 | $20.6M | Sell |
153,141
-671
| -0.4% | -$98.4K | 0.96% | 23 |
|
|
2023
Q1 | $24.5M | Buy |
153,812
+587
| +0.4% | +$89.7K | 1.3% | 15 |
|
|
2022
Q4 | $24.8M | Buy |
153,225
+5,943
| +4% | +$911K | 1.31% | 15 |
|
|
2022
Q3 | $19.8M | Buy |
147,282
+26,055
| +21% | +$3.74M | 1.15% | 19 |
|
|
2022
Q2 | $18.6M | Sell |
121,227
-2,580
| -2% | -$394K | 1.04% | 20 |
|
|
2022
Q1 | $20.1M | Buy |
123,807
+1,343
| +1% | +$195K | 1.04% | 17 |
|
|
2021
Q4 | $16.6M | Buy |
122,464
+829
| +0.7% | +$97.9K | 0.87% | 26 |
|
|
2021
Q3 | $13.1M | Sell |
121,635
-338
| -0.3% | -$38.6K | 0.78% | 32 |
|
|
2021
Q2 | $13.7M | Sell |
121,973
-4,407
| -3% | -$496K | 0.84% | 30 |
|
|
2021
Q1 | $13.7M | Sell |
126,380
-8,999
| -7% | -$963K | 0.9% | 27 |
|
|
2020
Q4 | $14.5M | Sell |
135,379
-692
| -0.5% | -$66.5K | 1% | 20 |
|
|
2020
Q3 | $11.9M | Sell |
136,071
-6,287
| -4% | -$592K | 0.93% | 30 |
|
|
2020
Q2 | $14M | Sell |
142,358
-1,770
| -1% | -$156K | 1.18% | 13 |
|
|
2020
Q1 | $11M | Sell |
144,128
-1,930
| -1% | -$164K | 1.1% | 19 |
|
|
2019
Q4 | $12.9M | Buy |
146,058
+971
| +0.7% | +$80.6K | 1.05% | 21 |
|
|
2019
Q3 | $11M | Buy |
145,087
+7,436
| +5% | +$510K | 0.99% | 25 |
|
|
2019
Q2 | $10M | Buy |
137,651
+440
| +0.3% | +$34.6K | 0.93% | 29 |
|
|
2019
Q1 | $11.1M | Buy |
137,211
+223
| +0.2% | +$18.2K | 1.11% | 19 |
|
|
2018
Q4 | $12.6M | Buy |
136,988
+2,008
| +1% | +$177K | 1.41% | 16 |
|
|
2018
Q3 | $12.8M | Sell |
134,980
-4,568
| -3% | -$433K | 1.3% | 16 |
|
|
2018
Q2 | $12.9M | Buy |
139,548
+2,885
| +2% | +$282K | 1.42% | 12 |
|
|
2018
Q1 | $12.9M | Buy |
136,663
+5,658
| +4% | +$622K | 1.47% | 11 |
|
|
2017
Q4 | $12.7M | Sell |
131,005
-1,050
| -0.8% | -$99K | 1.39% | 15 |
|
|
2017
Q3 | $11.7M | Buy |
132,055
+1,195
| +0.9% | +$91K | 1.36% | 15 |
|
|
2017
Q2 | $9.49M | Buy |
130,860
+4,663
| +4% | +$313K | 1.16% | 21 |
|
|
2017
Q1 | $8.22M | Buy |
126,197
+1,805
| +1% | +$113K | 1.07% | 24 |
|
|
2016
Q4 | $7.79M | Sell |
124,392
-1,661
| -1% | -$101K | 1.1% | 25 |
|
|
2016
Q3 | $7.95M | Buy |
126,053
+708
| +0.6% | +$45.8K | 1.2% | 24 |
|
|
2016
Q2 | $7.76M | Buy |
125,345
+1,030
| +0.8% | +$62.8K | 1.19% | 24 |
|
|
2016
Q1 | $7.1M | Buy |
124,315
+1,655
| +1% | +$92.2K | 1.09% | 22 |
|
|
2015
Q4 | $7.27M | Buy |
122,660
+63
| +0.1% | +$3.63K | 1.15% | 23 |
|
|
2015
Q3 | $6.67M | Buy |
122,597
+4,170
| +4% | +$271K | 1.14% | 22 |
|
|
2015
Q2 | $7.96M | Buy |
118,427
+5,689
| +5% | +$371K | 1.28% | 16 |
|
|
2015
Q1 | $6.6M | Buy |
112,738
+12,497
| +12% | +$755K | 1.13% | 22 |
|
|
2014
Q4 | $6.56M | Buy |
100,241
+3,289
| +3% | +$207K | 1.17% | 20 |
|
|
2014
Q3 | $5.6M | Buy |
96,952
+3,188
| +3% | +$177K | 1.06% | 24 |
|
|
2014
Q2 | $5.29M | Buy |
93,764
+5,775
| +7% | +$303K | 1.02% | 26 |
|
|
2014
Q1 | $4.52M | Buy |
87,989
+3,557
| +4% | +$180K | 0.81% | 37 |
|
|
2013
Q4 | $4.46M | Buy |
84,432
+2,725
| +3% | +$134K | 0.81% | 35 |
|
|
2013
Q3 | $3.65M | Buy |
81,707
+5,296
| +7% | +$235K | 0.72% | 42 |
|
|
2013
Q2 | $3.16M | Buy |
+76,411
| New | +$3.34M | 0.65% | 45 |
|
Other funds holding ABBV
VCM
VPM
First National Trust's ABBV Position: Q1 2026 in Review
First National Trust reduced its AbbVie (ABBV) stake by 25% in Q1 2026, selling an estimated $6.38M and leaving 87,859 shares worth $19.1M. The position accounts for 0.65% of the portfolio, ranked #41.
First National Trust first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $28.6M in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- First National Trust held 87,859 shares of AbbVie worth $19.1M as of Q1 2026.
- First National Trust sold 28,779 AbbVie shares in Q1 2026, an estimated $6.38M.
- AbbVie made up 0.65% of First National Trust's portfolio in Q1 2026, its #41 holding.
- First National Trust first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- First National Trust's AbbVie position peaked at $28.6M in Q3 2025.
- 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on First National Trust's 13F filing for Q1 2026, filed 7 May 2026.